Skip to main content
. 2014 Apr 10;2014(4):CD008965. doi: 10.1002/14651858.CD008965.pub4

NCT00958776.

Methods A study to evaluate the efficacy and safety of IV peramivir in addition to standard of care compared to standard of care alone in adults and adolescents who are hospitalised due to influenza
Sponsor: BioCryst Pharmaceuticals
Participants Peramivir
Interventions
Outcomes
Notes Awaiting assessment as we do not yet have the clinical study reports for this study